| 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT M Gabriel, C Decristoforo, D Kendler, G Dobrozemsky, D Heute, ... Journal of nuclear medicine 48 (4), 508-518, 2007 | 1213 | 2007 |
| Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE I Virgolini, V Ambrosini, JB Bomanji, RP Baum, S Fanti, M Gabriel, ... European journal of nuclear medicine and molecular imaging 37, 2004-2010, 2010 | 531 | 2010 |
| Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA MF Bozkurt, I Virgolini, S Balogova, M Beheshti, D Rubello, C Decristoforo, ... European journal of nuclear medicine and molecular imaging 44, 1588-1601, 2017 | 471 | 2017 |
| 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour C Uprimny, AS Kroiss, C Decristoforo, J Fritz, E von Guggenberg, ... European journal of nuclear medicine and molecular imaging 44, 941-949, 2017 | 352 | 2017 |
| 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? F Ceci, C Uprimny, B Nilica, L Geraldo, D Kendler, A Kroiss, J Bektic, ... European journal of nuclear medicine and molecular imaging 42, 1284-1294, 2015 | 320 | 2015 |
| 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison … C Decristoforo, SJ Mather, W Cholewinski, E Donnemiller, G Riccabona, ... European journal of nuclear medicine 27, 1318-1325, 2000 | 257 | 2000 |
| 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide C Decristoforo, L Melendez-Alafort, JK Sosabowski, SJ Mather Journal of Nuclear Medicine 41 (6), 1114-1119, 2000 | 257 | 2000 |
| Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy D Putzer, M Gabriel, B Henninger, D Kendler, C Uprimny, G Dobrozemsky, ... Journal of Nuclear Medicine 50 (8), 1214-1221, 2009 | 247 | 2009 |
| An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors M Gabriel, C Decristoforo, E Donnemiller, H Ulmer, CW Rychlinski, ... Journal of nuclear medicine 44 (5), 708-716, 2003 | 244 | 2003 |
| Brain perfusion scintigraphy with99mTc-HMPAO or99mTc-ECD and123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse … E Donnemiller, J Heilmann, GK Wenning, W Berger, C Decristoforo, ... European journal of nuclear medicine 24, 320-325, 1997 | 236 | 1997 |
| 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor–mediated radionuclide therapy M Gabriel, A Oberauer, G Dobrozemsky, C Decristoforo, D Putzer, ... Journal of Nuclear Medicine 50 (9), 1427-1434, 2009 | 233 | 2009 |
| 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression C Decristoforo, I Hernandez Gonzalez, J Carlsen, M Rupprich, ... European journal of nuclear medicine and molecular imaging 35, 1507-1515, 2008 | 221 | 2008 |
| [68Ga]NODAGA-RGD for imaging αvβ3 integrin expression PA Knetsch, M Petrik, CM Griessinger, C Rangger, M Fani, ... European journal of nuclear medicine and molecular imaging 38, 1303-1312, 2011 | 203* | 2011 |
| Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals P Elsinga, S Todde, I Penuelas, G Meyer, B Farstad, A Faivre-Chauvet, ... European journal of nuclear medicine and molecular imaging 37, 1049-1062, 2010 | 187 | 2010 |
| 99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution C Decristoforo, SJ Mather Nuclear medicine and biology 26 (4), 389-396, 1999 | 184 | 1999 |
| Current status of theranostics in prostate cancer I Virgolini, C Decristoforo, A Haug, S Fanti, C Uprimny European journal of nuclear medicine and molecular imaging 45, 471-495, 2018 | 179 | 2018 |
| Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I … A Kroiss, D Putzer, C Uprimny, C Decristoforo, M Gabriel, W Santner, ... European journal of nuclear medicine and molecular imaging 38, 865-873, 2011 | 172 | 2011 |
| Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours L Kabasakal, E Demirci, M Ocak, C Decristoforo, A Araman, Y Ozsoy, ... European journal of nuclear medicine and molecular imaging 39, 1271-1277, 2012 | 171 | 2012 |
| [99mTc] HYNIC-RGD for imaging integrin αvβ3 expression C Decristoforo, B Faintuch-Linkowski, A Rey, E von Guggenberg, ... Nuclear medicine and biology 33 (8), 945-952, 2006 | 168 | 2006 |
| Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence C Decristoforo, SJ Mather European journal of nuclear medicine 26, 869-876, 1999 | 158 | 1999 |
Hubertus HaasProfessor, Microbiology, Biocenter, Medical University InsbruckZweryfikowany adres z i-med.ac.at